In 2060, a quarter of the Brazilian population will be over 65 years of age. This represents 25.5% of the population, while in 2018, this proportion is 9.2%. In this scenario, it is clear that Brazil has a growing domestic market for service goods and is especially promising in the health sector.
What We OfferConduct market research for your product or service in Brazil.
Find the best local distribution and sales partners for your business.
Identify Key Opinion Leaders within the Brazilian market
Guide you through the product approval process (ANVISA & MAPA capabilities)
Act as your local representative during your expansion
Assist you with your clinical trials
MedHub provides consulting services to healthcare companies seeking to enter the Brazilian market. With a population of over 200m, Brazil is one of the world’s leading “pharmerging” economies.
At MedHub we simplify access to Brazil by facilitating, clinical trials, product registration, KOL access, business development, and partnerships.
We specialize in advising Pharmaceutical, Diagnostic and Medical Device businesses seeking to commercialize their products in Brazil. We have experience working with both the human healthcare and animal health industries.
We are a team of specialists with experience at leading healthcare companies in the US, Europe and Latin America. We are based in Sao Paulo and can offer all the local support services needed for your business to be successful in Brazil.
Our team is able to provide service in English, Spanish, Portuguese and Chinese Mandarim.
We are based in Sao Paulo and can offer all the local support services needed for your business to be successful in Brazil.
Contact Us
Liu is a PharmD with over 20 years of experience in the pharmaceutical, in-vitro diagnostics, and medical devices industry, having held several Brazilian leadership positions at Bayer, Roche, CSL Behring and The Medicines Company . His specialty is Brazilian business development & regulatory affairs, with extensive experience collaborating with ANVISA and other regulatory agencies. Liu received his PharmD degree from the University of Sao Paulo and his MBA from the University of California Los Angeles (UCLA).
Bernardo is a healthcare and technology executive with experience in business development, M&A and go-to-market strategy for pharmaceuticals. He was Chief of Staff to the CEO of the Medicines Company (acquired by Novartis in 2019), where he led the company’s Latin America expansion strategy. He is also co-founder and Chairman of 4Vets, an online veterinary pharma procurement platform for the Brazilian market. Bern received his AB in Economics from the University of Chicago and his MBA in Healthcare Management from the Wharton School of the University of Pennsylvania.
Patrícia is a Brazilian executive with a solid background in business valuation, risk management, and corporate governance. She holds a bachelor of accountancy and a MSc degree in Accounting from the University of Sao Paulo. Also, Patrícia received an undergraduate degree in mathematics from the same institution.
.png)